Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
TMEM123 a key player in immune surveillance of colorectal cancer.
Pesce E, Cordiglieri C, Bombaci M, Eppenberger-Castori S, Oliveto S, Manara C, Crosti M, Ercan C, Coto M, Gobbini A, Campagnoli S, Donnarumma T, Martinelli M, Bevilacqua V, De Camilli E, Gruarin P, Sarnicola ML, Cassinotti E, Baldari L, Viale G, Biffo S, Abrignani S, Terracciano LM, Grifantini R. Pesce E, et al. Among authors: de camilli e. Front Immunol. 2023 Jun 23;14:1194087. doi: 10.3389/fimmu.2023.1194087. eCollection 2023. Front Immunol. 2023. PMID: 37426665 Free PMC article.
Assessment of selective homing and contribution to vessel formation of cryopreserved peripherally injected bone marrow mononuclear cells following experimental myocardial damage.
Ciulla MM, Ferrero S, Montelatici E, Gianelli U, Braidotti P, Calderoni S, Paliotti R, Annoni G, De Camilli E, Busca G, Magrini F, Bosari S, Lazzari L, Rebulla P. Ciulla MM, et al. Among authors: de camilli e. Cardiovasc Hematol Disord Drug Targets. 2006 Sep;6(3):141-9. doi: 10.2174/187152906778249563. Cardiovasc Hematol Disord Drug Targets. 2006. PMID: 17017899
A novel polyclonal antibody library for expression profiling of poorly characterized, membrane and secreted human proteins.
Grifantini R, Pagani M, Pierleoni A, Grandi A, Parri M, Campagnoli S, Pileri P, Cattaneo D, Canidio E, Pontillo A, De Camilli E, Bresciani A, Marinoni F, Pedrazzoli E, Nogarotto R, Abrignani S, Viale G, Sarmientos P, Grandi G. Grifantini R, et al. Among authors: de camilli e. J Proteomics. 2011 Dec 21;75(2):532-47. doi: 10.1016/j.jprot.2011.08.018. Epub 2011 Sep 5. J Proteomics. 2011. PMID: 21920474
Angiopoietin-like 7, a novel pro-angiogenetic factor over-expressed in cancer.
Parri M, Pietrovito L, Grandi A, Campagnoli S, De Camilli E, Bianchini F, Marchiò S, Bussolino F, Jin B, Sarmientos P, Grandi G, Viale G, Pileri P, Chiarugi P, Grifantini R. Parri M, et al. Among authors: de camilli e. Angiogenesis. 2014 Oct;17(4):881-96. doi: 10.1007/s10456-014-9435-4. Epub 2014 Jun 6. Angiogenesis. 2014. PMID: 24903490
FAT1: a potential target for monoclonal antibody therapy in colon cancer.
Pileri P, Campagnoli S, Grandi A, Parri M, De Camilli E, Song C, Ganfini L, Lacombe A, Naldi I, Sarmientos P, Cinti C, Jin B, Grandi G, Viale G, Terracciano L, Grifantini R. Pileri P, et al. Among authors: de camilli e. Br J Cancer. 2016 Jun 28;115(1):40-51. doi: 10.1038/bjc.2016.145. Epub 2016 Jun 21. Br J Cancer. 2016. PMID: 27328312 Free PMC article.
ERMP1, a novel potential oncogene involved in UPR and oxidative stress defense, is highly expressed in human cancer.
Grandi A, Santi A, Campagnoli S, Parri M, De Camilli E, Song C, Jin B, Lacombe A, Castori-Eppenberger S, Sarmientos P, Grandi G, Viale G, Terracciano L, Chiarugi P, Pileri P, Grifantini R. Grandi A, et al. Among authors: de camilli e. Oncotarget. 2016 Sep 27;7(39):63596-63610. doi: 10.18632/oncotarget.11550. Oncotarget. 2016. PMID: 27566589 Free PMC article.
Magnetically driven drug delivery systems improving targeted immunotherapy for colon-rectal cancer.
Grifantini R, Taranta M, Gherardini L, Naldi I, Parri M, Grandi A, Giannetti A, Tombelli S, Lucarini G, Ricotti L, Campagnoli S, De Camilli E, Pelosi G, Baldini F, Menciassi A, Viale G, Pileri P, Cinti C. Grifantini R, et al. Among authors: de camilli e. J Control Release. 2018 Jun 28;280:76-86. doi: 10.1016/j.jconrel.2018.04.052. Epub 2018 May 4. J Control Release. 2018. PMID: 29733876
Corrigendum: TMEM123 a key player in immune surveillance of colorectal cancer.
Pesce E, Cordiglieri C, Bombaci M, Eppenberger-Castori S, Oliveto S, Manara C, Crosti M, Ercan C, Coto M, Gobbini A, Campagnoli S, Donnarumma T, Martinelli M, Bevilacqua V, De Camilli E, Gruarin P, Sarnicola ML, Cassinotti E, Baldari L, Viale G, Biffo S, Abrignani S, Terracciano LM, Grifantini R. Pesce E, et al. Among authors: de camilli e. Front Immunol. 2023 Jul 28;14:1256713. doi: 10.3389/fimmu.2023.1256713. eCollection 2023. Front Immunol. 2023. PMID: 37575239 Free PMC article.
Standardized pathology report for HER2 testing in compliance with 2023 ASCO/CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer.
Ivanova M, Porta FM, D'Ercole M, Pescia C, Sajjadi E, Cursano G, De Camilli E, Pala O, Mazzarol G, Venetis K, Guerini-Rocco E, Curigliano G, Viale G, Fusco N. Ivanova M, et al. Among authors: de camilli e. Virchows Arch. 2024 Jan;484(1):3-14. doi: 10.1007/s00428-023-03656-w. Epub 2023 Sep 28. Virchows Arch. 2024. PMID: 37770765 Free PMC article. Review.
25 results